Income Statement Balance Sheet Cash Flow Statement
Annual Financials for China Pharma Holdings Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 61.7M 74.39M 74.39M 54.51M 32.81M
Cost of Goods Sold (COGS) incl. D&A 36.05M 44.11M 44.11M 41.04M 34.05M
COGS excluding D&A 34.68M 42.6M 42.6M 39.58M 32.44M
Depreciation & Amortization Expense 1.37M 1.51M 1.51M 1.46M 1.61M
Depreciation 559,204 591,562 591,562 851,047 846,512
Amortization of Intangibles 809,684 913,633 913,633 611,724 766,318
Gross Income 25.65M 30.28M 30.28M 13.46M (1.25M)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.85M 6.09M 6.09M 7.11M 17.36M
Research & Development 0 0 0 0 1.68M
Other SG&A 4.85M 6.09M 6.09M 7.11M 15.68M
Other Operating Expense (1.82M) 0 0 0 0
Unusual Expense 0 (1.59M) (1.59M) 593,095 0
EBIT after Unusual Expense 0 1.59M 1.59M (593,095) 0
Non Operating Income/Expense 3,540 469,509 469,509 0 0
Non-Operating Interest Income 30,695 15,413 15,413 4,944 8,457
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 154,182 168,258 168,258 308,375 348,696
Gross Interest Expense 154,182 168,258 168,258 308,375 583,400
Interest Capitalized 0 0 0 0 234,704
Pretax Income 22.49M 26.1M 26.1M 5.6M (18.95M)
Income Tax 2.26M 2.69M 2.69M 983,921 1.06M
Income Tax - Current Domestic 2.12M 2.81M 2.81M 1.41M 0
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 142,846 (123,177) (123,177) (430,250) 1.06M
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 20.23M 23.41M 23.41M 4.62M (20.01M)
Minority Interest Expense 0 0 0 0 0
Net Income 20.23M 23.41M 23.41M 4.62M (20.01M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 20.23M 23.41M 23.41M 4.62M (20.01M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 20.23M 23.41M 23.41M 4.62M (20.01M)
EPS (Basic) 0.48 0.54 0.54 0.11 (0.46)
Basic Shares Outstanding 42.28M 43.33M 43.33M 43.58M 43.58M
EPS (Diluted) 0.48 0.54 0.54 0.11 (0.46)
Diluted Shares Outstanding 42.28M 43.53M 43.53M 43.58M 43.58M
EBITDA 23.98M 25.7M 25.7M 7.82M (16.99M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.